Regulation of human D-1, D-2(long), D-2(short), D-3 and D-4 dopamine receptors by amiloride and amiloride analogues

Hoare, S.R.J. and Coldwell, M.C. and Armstrong, C. and Strange, Philip G. (2000) Regulation of human D-1, D-2(long), D-2(short), D-3 and D-4 dopamine receptors by amiloride and amiloride analogues. British Journal of Pharmacology, 130 (5). pp. 1045-1059. ISSN 0007-1188. (The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided)

The full text of this publication is not currently available from this repository. You may be able to access a copy if URLs are provided. (Contact us about this Publication)
Official URL
http://dx.doi.org/10.1038/sj.bjp.0703370

Abstract

1 The modulatory effects of the allosteric effecters methylisobutylamiloride (MIA), benzamil and amiloride have been examined at human D-1, D-2, D-3 and D-4 dopamine receptors. The subtype selectivity and the mechanism of action of this allosteric regulation was examined. 2 In radioligand dissociation experiments each modulator accelerated dissociation from all four receptor subtypes indicating allosteric regulation. MIA displayed selectivity for the D-3 subtype for acceleration of radioligand dissociation. 3 In equilibrium binding (pseudo-competition) experiments the three compounds inhibited radioligand binding at the four receptor subtypes. Inhibition curves for D-1, D-2(short), D-2(long) and D-3 receptors were described by Hill coefficients exceeding unity and data were fitted best by a model that assumes binding of modulator to both the primary and allosteric binding sites of the receptor (the allosteric/competitive model). 4 At the D-4 subtype, Hill coefficients of unity described the binding data for amiloride and benzamii, consistent with competitive inhibition. The Hill coefficient for MIA at the D-4 subtype was less than unity and data could be fitted well by the allosteric/competitive model, but it was not possible to define unambiguously the modulatory mechanism. For this effect a better definition of the mechanism could be obtained by simultaneous analysis of data obtained in the presence of a range of concentrations of a purely competitive ligand. 5 MIA reduced the potency with which dopamine stimulated [S-35]-GTP gamma S binding at: the D-2 receptor. The effects of MIA could be described by the allosteric/competitive model with effects of MIA to inhibit the binding of dopamine but not its ability to induce a response.

Item Type: Article
Uncontrolled keywords: dopamine receptors (D-1,D-2, D-3, D-4); allosteric regulation; amiloride; radioligand dissociation; radioligand binding
Subjects: R Medicine
R Medicine > RS Pharmacy and materia medica
Divisions: Faculties > Science Technology and Medical Studies > School of Biosciences
Depositing User: O.O. Odanye
Date Deposited: 03 Apr 2009 10:25
Last Modified: 16 Apr 2014 15:21
Resource URI: https://kar.kent.ac.uk/id/eprint/16216 (The current URI for this page, for reference purposes)
  • Depositors only (login required):